SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-382015
Filing Date
2015-11-19
Accepted
2015-11-19 15:01:11
Documents
1
Effectiveness Date
2015-11-19

Document Format Files

Seq Description Document Type Size
1 8-K d215168d8k.htm DEFA14A 27057
  Complete submission text file 0001193125-15-382015.txt   28193
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35703 | Film No.: 151243467
SIC: 2834 Pharmaceutical Preparations